Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Clinical trial NCT07201558 · RECRUITING

Trial details

NCT number: NCT07201558
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis Systemic Lupus Erythematosus

Start date: 2025-12-02
Primary completion: 2028-06-27
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.